The 2', 3'-cyclic AMP 3'-phosphohydrolase in normal and psoriatic epidermis. 1979

M Mezei, and D R Howell

The activity of the enzyme 2', 3'-cyclic AMP 3'-phosphohydrolase is significantly greater in the 'involved' psoriatic skin than in the 'uninvolved' psoriatic skin or in skin samples taken from persons having clinically normal skin. Although the physiological function of this enzyme is not established, it is possible that, besides being associated with myelin, it may also play some role in cell proliferation and maturation, probably at the membrane level.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010727 Phosphoric Diester Hydrolases A class of enzymes that catalyze the hydrolysis of one of the two ester bonds in a phosphodiester compound. EC 3.1.4. Phosphodiesterase,Phosphodiesterases,Hydrolases, Phosphoric Diester
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D015087 2',3'-Cyclic-Nucleotide Phosphodiesterases Nucleoside-2',3'-cyclic phosphate nucleotidohydrolase. Enzymes that catalyze the hydrolysis of the 2'- or 3'- phosphate bonds of 2',3'-cyclic nucleotides. Also hydrolyzes nucleoside monophosphates. Includes EC 3.1.4.16 and EC 3.1.4.37. EC 3.1.4.-. 2',3'-Cyclic Nucleotide Phosphodiesterase,2',3'-Cyclic Nucleotide Phosphodiesterases,2,3-Cyclic Nucleotide Phosphodiesterase,2,3-Cyclic Nucleotide Phosphodiesterases,CNPase,2',3' Cyclic Nucleotide Phosphodiesterase,2',3' Cyclic Nucleotide Phosphodiesterases,2,3 Cyclic Nucleotide Phosphodiesterase,2,3 Cyclic Nucleotide Phosphodiesterases,Nucleotide Phosphodiesterase, 2',3'-Cyclic,Nucleotide Phosphodiesterase, 2,3-Cyclic,Nucleotide Phosphodiesterases, 2',3'-Cyclic,Nucleotide Phosphodiesterases, 2,3-Cyclic,Phosphodiesterase, 2',3'-Cyclic Nucleotide,Phosphodiesterase, 2,3-Cyclic Nucleotide,Phosphodiesterases, 2',3'-Cyclic Nucleotide,Phosphodiesterases, 2',3'-Cyclic-Nucleotide,Phosphodiesterases, 2,3-Cyclic Nucleotide

Related Publications

M Mezei, and D R Howell
July 1972, The Journal of investigative dermatology,
M Mezei, and D R Howell
January 1982, Dermatologica,
M Mezei, and D R Howell
March 1974, Journal of neurochemistry,
M Mezei, and D R Howell
September 1975, The British journal of dermatology,
M Mezei, and D R Howell
February 1979, The British journal of dermatology,
M Mezei, and D R Howell
January 1981, Acta dermato-venereologica,
M Mezei, and D R Howell
March 1987, Chinese medical journal,
M Mezei, and D R Howell
April 1980, The Journal of dermatology,
M Mezei, and D R Howell
March 1972, Journal of neurochemistry,
Copied contents to your clipboard!